Menu
Log in
Log in

ANCO - Education and Empowering the Northern California Cancer Community

Upcoming events

    • 05/31/2026
    • 11:30 AM - 1:30 PM
    • Hyatt Regency McCormick Place, Chicago


    This lunch is for all ANCO and MOASC MD, Fellows, and Prospective MD and Fellow Members who are attending the ASCO Annual Meeting. This meeting is for practitioners only; industry representatives may not attend.

    Lunch will be served from 11:30am - 1:30pm at the Hyatt Regency McCormick Place in the Regency CD room. Come by whenever you can!

    This is not an official event of the 2026 ASCO Annual Meeting. It is not sponsored, endorsed, or accredited by ASCO or Conquer Cancer®, the ASCO Foundation. Please let us know if you plan to attend by Monday, May 18th. 

    • 08/14/2026
    • 5:45 PM - 9:30 PM
    • Oracle Park
    Register


    ANCO wants to take you out to the ballgame! Join us at Oracle Park on Friday, August 14th, for an evening of camaraderie, connection, and San Francisco Giants!  This exclusive, practitioner-only event is curated specifically for our member community to network, relax, and enjoy the game in style. Spend Friday night unwinding with colleagues, then join us Saturday for ANCO’s ASCO26 Highlights (complimentary to members) for a high-impact review distilling the latest practice-changing data into actionable clinical insights.

    The Game Plan:

    • 5:45 PM: Kick things off in our exclusive ANCO Lounge. Enjoy hosted appetizers and beverages while catching up with colleagues before the crowds arrive.
    • 7:15 PM: Game Time - We’ll head to our group seats to watch the Giants take on the Rockies.
    Registration:
    ANCO MD Members: $30. Each ANCO member can register up to two guests at $60 each. Every ticket comes with a $10 Splash Pass to use for ballpark snacks or that Giants cap you’ve been eyeing!  Note: This is a practitioner-only event.

    Ticket Info:
    Your digital tickets will be emailed directly to you on August 7th (one week before the game). Please ensure your email address we have in our database is current.

    • 08/15/2026
    • 10:00 AM - 4:15 PM
    • InterContinental San Francisco


    Join us for ANCO’s ASCO26 Highlights taking place at the InterContinental San Francisco on August 15, 2026. 


    This meeting is complimentary for all ANCO health care provider members!


    Meeting Overview

    Join us for ANCO’s ASCO26 Highlights, a high-impact review designed to present the most practice-changing data from the world’s premier oncology stage into actionable clinical insights.

    This isn't just a summary—it’s a roadmap for the future of oncology. Our expert faculty will bridge the gap between late-breaking research and your practice, placing every advancement into the context of immediate clinical utility.


    Industry Registration

    Please read below to understand ANCO's industry registration waitlist process. 

    At ANCO, we strive to foster meaningful connections and facilitate valuable interactions among participants at our meetings. To ensure a fair distribution of attendance and provide an opportunity for various stakeholders to participate and engage with the cancer care community at large, industry registrations for our meetings are intentionally limited. Industry Registrations are limited to a maximum of three representatives per company, from companies who are not exhibiting at the meeting, with a maximum of 15 companies.

    This policy is contingent upon meeting registrations and venue capacity. If we do have additional space, we will accept more representatives.

    How does the ANCO Industry Registration waitlist approval process work?

    • Six weeks prior to the meeting starting, ANCO will begin approving industry registrations from the waitlist, priority will be given to industry representatives who are not exhibiting.
    • Two weeks prior to ANCO meetings, ANCO will review the remaining waitlisted industry registrations. If additional space is available, ANCO may approve up to three additional industry registrations per company on the waitlist.
    • 09/19/2026
    • 7:30 AM - 2:30 PM
    • Claremont Resort & Club, Berkeley, CA


    Join us for the Northern California Genitourinary Cancer Research Forum taking place at the Claremont Resort & Club, September 19, 2026!

    Meeting Overview

    Clinical trials are the engine of progress in oncology, offering the most promising potential therapies and, often, the treatment of choice for cancer patients. However, navigating the landscape of trial enrollment—especially for genitourinary malignancies—requires a specialized, collaborative, and patient-centered approach that is rarely incorporated in standard continuing medical education.

    We invite you to join us for an innovative one-day educational meeting that bridges this critical gap. This forum convenes leading academic and community clinicians and researchers to enhance collaboration, share cutting-edge science, and strategize on best practices for clinical trial participation in kidney, bladder, and prostate cancer.

    Registration

    Registration will open in spring 2026.

    Industry Registration

    What is ANCO’s Industry Registration policy?

    At ANCO, we strive to foster meaningful connections and facilitate valuable interactions among participants at our meetings. To ensure a fair distribution of attendance and provide an opportunity for various stakeholders to participate and engage with the cancer care community at large, industry registrations for our meetings are intentionally limited.Industry Registrations are limited to a maximum of three representatives per company, from companies who are not exhibiting at the meeting, with a maximum of 15 companies.

    This policy is contingent upon meeting registrations and venue capacity. If we do have additional space, we will accept more representatives.

    How does the ANCO Industry Registration waitlist approval process work?

    • Six weeks prior to the meeting starting, ANCO will begin approving industry registrations from the waitlist, priority will be given to industry representatives who are not exhibiting.
    • Two weeks prior to ANCO meetings, ANCO will review the remaining waitlisted industry registrations. If additional space is available, ANCO may approve up to three additional industry registrations per company on the waitlist.
    • 11/07/2026
    • Intercontinental San Francisco, 888 Howard Street, San Francisco, CA 94103


    Join us for ANCO & MOASC Present: Precision Oncology Symposium 2026 taking place at the InterContinental San Francisco, November 7, 2026!


    Meeting Overview

    Precision oncology promises to improve the outcomes of patients through broad molecular diagnostic profiling and individualized treatment recommendations. Recent FDA approvals of new cancer treatments that are based on molecular tumor features and not disease type underscore the relevance of this approach.

    However, the landscape of available diagnostic technologies and targeted drugs is rapidly changing, making it extremely difficult for practicing oncologists and related professionals to stay up to date and to offer their patients the best molecular diagnostic approach possible. By attending this meeting, clinicians will be informed on cutting edge technologies and their optimal clinical application.

    Registration

    Registration will open in spring 2026.

    Industry Registration

    What is ANCO’s Industry Registration policy?

    At ANCO, we strive to foster meaningful connections and facilitate valuable interactions among participants at our meetings. To ensure a fair distribution of attendance and provide an opportunity for various stakeholders to participate and engage with the cancer care community at large, industry registrations for our meetings are intentionally limited.Industry Registrations are limited to a maximum of three representatives per company, from companies who are not exhibiting at the meeting, with a maximum of 15 companies.

    This policy is contingent upon meeting registrations and venue capacity. If we do have additional space, we will accept more representatives.

    How does the ANCO Industry Registration waitlist approval process work?

    • ANCO meetings have spots for up to 45 industry registrations, outside of exhibitors (only exception is MMC, as we go up to 120 Industry).
    • Once all exhibitors have confirmed their registrants, ANCO will determine how many industry registration spots are available, and will review the waitlist.
    • Six weeks prior to the meeting starting, ANCO will begin approving industry registrations from the waitlist, priority will be given to industry representatives who are not exhibiting.
    • Two weeks prior to ANCO meetings, ANCO will review the remaining waitlisted industry registrations. If additional space is available, ANCO may approve up to three additional industry registrations per company on the waitlist.

Past events

05/07/2026 Stanford Blood and Marrow Transplantation and Cellular Therapy Symposium
05/02/2026 Hematologic Malignancies Update 2026
04/24/2026 Harvesting Knowledge: A Summit on Multiple Myeloma
03/06/2026 26th Multidisciplinary Management of Cancers: A Case-Based Approach
02/14/2026 Best of SABCS®️ - West
01/23/2026 Clinical Cancer Update 2026
01/14/2026 ANCO's Medicare Regulations Update 2026
01/09/2026 Annual ANCO Meet & Greet with the Board, Dinner, and Board Breakfast Meeting
11/04/2025 2025 Melanoma Scientific Updates Patient Symposium
10/25/2025 ANCO & MOASC Present: Improving Cancer Care Access for Californians
10/20/2025 ANCO & MOASC Present – Breakdown: Big Beautiful Bill’s Impact on the Future of Healthcare in California
10/10/2025 NCCN 2025 Annual Congress: Hematologic Malignancies
09/26/2025 The Leadership, Empowerment, And Development (LEAD) Conference
09/23/2025 Cancer Navigation: Where is my GPS?
09/06/2025 MOASC & ANCO Present: Immuno-Oncology Symposium 2025
08/16/2025 ANCO's ASCO25 Highlights
06/12/2025 Navigating the DMHC’s Provider Complaint Process – A Physician’s Guide
05/07/2025 SoCOE 2025: Optimizing Cancer Research, Care & Outcomes for All
05/03/2025 Hematologic Malignancies Update 2025
05/02/2025 Optimizing CLL Care in Northern California
04/26/2025 Navigating Your Breast Cancer Experience Workshop
03/07/2025 25th Multidisciplinary Management of Cancers: A Case-Based Approach
02/08/2025 Stanford University's The Steven Coutre Review of the 66th Annual American Society of Hematology Meeting
01/31/2025 Clinical Cancer Update 2025
01/11/2025 Best of SABCS® – West
11/02/2024 Precision Oncology Symposium 2024
09/27/2024 ASCO Quality Care Symposium
09/27/2024 LEAD 2024
08/17/2024 ANCO's ASCO24 Highlights
05/21/2024 Caring for the Caregiver Roundtable
05/04/2024 ANCO's Hematologic Malignancies Update 2024
04/04/2024 2024 Stanford Blood and Marrow Transplantation and Cancer Cell Therapy Symposium-
03/15/2024 24th Multidisciplinary Management of Cancers: A Case-Based Approach
02/28/2024 A Treatment Option for Patients with Unresectable or Metastatic Melanoma Regardless of BRAF Status & Metastatic NSCLC Regardless of PD-L1 Expression
02/10/2024 Stanford University's The Steven Coutre Review of the 65th Annual American Society of Hematology Meeting
02/02/2024 Clinical Cancer Update 2024
01/27/2024 Best of SABCS® – West
11/11/2023 MOASC And ANCO Present: Immuno-Oncology Symposium
10/13/2023 5th Annual LEAD 2023
09/22/2023 NCC 2023 Annual Congress: Hematologic Malignancies
09/11/2023 2nd Annual Cancer Center Survivorship Research Forum: Implementing Equitable Cancer Survivorship Care
09/09/2023 Health Equity Research Summit 2023
08/19/2023 ANCO's ASCO23 Highlights
07/27/2023 24th Annual International Lung Cancer Congress
06/06/2023 Sexual Health After Cancer
05/06/2023 ANCO's Hematologic Malignancies Update 2023
03/10/2023 23rd Multidisciplinary Management of Cancers
02/11/2023 The Steven Coutre Review of the 64th Annual American Society of Hematology Meeting
02/04/2023 Best of SABCS® - West - February 4th, 2023
11/12/2022 ANCO's Hematologic Malignancies Update 2022
11/05/2022 Precision Oncology Symposium
09/28/2022 UCSF Cancer Center Live Series #1- Updates in Surgical Treatment Options for Prostate and Breast Cancer
09/17/2022 ANCO's Hematologic Malignancies Update 2022
09/02/2022 The 2022 ASH Meeting on Hematologic Malignancies (MHM)
08/27/2022 ANCO's ASCO22 Highlights
07/28/2022 23rd Annual International Lung Cancer Congress
05/21/2022 Hematologic Malignancies Update 2022
04/07/2022 Stanford Cancer Cell Therapy and Blood and Marrow Transplant Symposium: Update on Current Advances in BMT and Cancer Cell Therapy in honor of Dr. Robert Negrin
03/17/2022 ANCO Connections: What It Is Like to be a Woman Oncology Leader Today
03/11/2022 22nd Multidisciplinary Management of Cancers: A Case-Based Approach
02/12/2022 Stanford's Steven Coutre Review of the 63rd Annual American Society of Hematology Meeting
02/12/2022 Best of SABCS-West - San Francisco - February 12, 2022
01/26/2022 MOASC Lung Cancer Webinar Series
01/20/2022 Gastrointestinal Cancers Symposium
01/10/2022 ANCO's Medicare Update for 2022
12/16/2021 ANCO Connections: Finding Meaning for Healthcare Professionals
11/06/2021 Hematologic Malignancies Updates: Leukemias, Lymphomas, & Myeloma 2021
10/30/2021 Best of IASLC WCLC 2021- San Francisco
10/27/2021 ANCO's Virtual Professional Education Conference
10/22/2021 Women in Oncology Symposium
10/22/2021 Is There a Future for Targeting BRAF in Melanoma?
10/14/2021 Western Colorectal Cancer Consortium Conference
09/11/2021 Hematologic Malignancies Updates: Leukemias, Lymphomas, & Myeloma 2021 - A Virtual Series
08/21/2021 ANCO's ASCO21 Highlights
08/19/2021 ANCO Connections Hematology/Oncology Career Forum
05/20/2021 ANCO Connections
05/15/2021 Hematologic Malignancies Updates:Leukemias, Lymphomas, & Myeloma 2021 – A Virtual Series
04/15/2021 Medicare in 2021: E&M Office Changes, Telehealth Status and Other Changes
04/08/2021 COA's 2021 Community Oncology Conference
03/12/2021 21st Multidisciplinary Management of Cancers: A Virtual Case-based Approach
03/01/2021 Highlights of ASH
02/13/2021 Stanford's Review of the 62nd Annual American Society of Hematology Meeting
01/28/2021 UCSF CME Integrative Oncology: Approaches for Enhancing Patient-Centered Palliative and Supportive Care 2021
01/09/2021 Virtual Best of SABCS - West
01/06/2021 ANCO's Medicare Update for 2021
12/19/2020 Hematologic Malignancies Updates: Leukemias, Lymphomas, & Myeloma- A Virtual Series
12/17/2020 Protecting the Secrets of the Brain– Central Nervous System Radiotherapy and Radiosurgery
12/16/2020 Cancer Center Grand Rounds Series: Advances in Hematologic Malignancies and CAR T-Cell Therapy
11/19/2020 Can Radiotherapy Cure Stage IV Cancer? The Future of Oligometastatic Cancer
11/17/2020 California Telehealth Policy Coalition Annual Meeting: Improving Access to Care in a Time of Crisis and Beyond
11/14/2020 Hematologic Malignancies Updates: Leukemias, Lymphomas, & Myeloma- A Virtual Series
11/12/2020 The One-Two Punch Knockout: Combining Radiotherapy and Immunotherapy in Cancers of the Skin, Head and Neck
11/05/2020 No Common Cold: Viruses can Cause HPV Related Cancers
11/04/2020 Helen Diller Family Comprehensive Cancer Center Grand Rounds Series
10/29/2020 No Beam Required! Inside-Out Radiotherapy: HDR Brachytherapy for Prostate Cancer
10/29/2020 ANCO's 2020 Virtual Professional Education Meeting
10/22/2020 Innovations In Cancer Treatment: Radiation Therapy in the Modern Era
10/22/2020 Close to the Heart: Modern Radiation Therapy for Breast Cancer Treatment
10/15/2020 Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know
10/13/2020 Effectiveness, efficiency and highest scientific standards – the TARGIT-A trial comparing single-dose IORT with EBRT upheld expectations
10/09/2020 ASCO Quality Care Syposium-Virtual
09/29/2020 Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know
09/12/2020 Hematologic Malignancies Updates: Leukemias, Lymphomas, & Myeloma- A Virtual Series
08/27/2020 ASH Meeting on Hematologic Malignancies
08/22/2020 ANCO’s ASCO20 Virtual Highlights
08/08/2020 ASCO Annual Meeting--Virtual Education Program
07/20/2020 AACR Virtual Meeting: COVID-19 and Cancer
06/26/2020 Stanford Brain Tumor Center Symposium: Breakthroughs in Brain Tumor Treatment 2020
06/19/2020 20th Multidisciplinary Management of Cancers: A Virtual Case-based Approach
05/29/2020 ASCO Annual Meeting--Virtual Scientific Program
05/07/2020 CalHIPSO Health IT Conference--CANCELLED
04/25/2020 AACR Annual Meeting--Virtual Meeting
04/02/2020 Stanford Cancer Cell Therapy and Blood and Marrow Transplant Symposium: Update on Current Advances in BMT and Cancer Cell Therapy
03/26/2020 1st Annual Western Colorectal Cancer Conference
03/14/2020 Exciting Advances in Oncology: MOASC Oncology Summit Annual Educational Symposium
02/15/2020 Stanford's Review of the 61st Annual ASH Annual Meeting
02/13/2020 Genitourinary Cancers Symposium
02/07/2020 TARGIT Collaborative Group 4th Annual Conference
02/01/2020 MOASC Spotlight on Hematology
01/30/2020 The ABCs of AB 5: Classifying Health Care Workers in California's Gig Economy
01/30/2020 Grand Rounds with Dr. Linda Carlson on “Mindfulness-Based Cancer Recovery
01/24/2020 Highlights of ASH
01/23/2020 Gastrointestinal Cancers Symposium
01/15/2020 Chronic Leukemia Rounds: Treatment of CLL and CML in a Rapidly Evolving Therapeutic Landscape--Application to Clinical Practice
01/11/2020 Best of SABCS Northern California
01/02/2020 ANCO's 2020 Medicare Update
11/23/2019 Best of WCLC 2019-San Francisco
11/22/2019 Perspectives in Thoracic Oncology
11/16/2019 ANCO's 4Q2019 Hematologic Malignancies Updates: Leukemias, Lymphomas, & Myeloma
11/16/2019 Multidisciplinary Management of NET Disease
11/09/2019 ANCO-UCSF Precision Oncology Symposium
11/08/2019 Kaiser Permanente National Oncology Symposium
10/25/2019 8th International Congress on Cancer Metastasis
10/25/2019 ASCO Supportive Care in Oncology Symposium
10/17/2019 ANCO's 2019 Professional Education Meeting
09/27/2019 NCCN Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies
09/27/2019 NCCN 2019 Annual Congress: Hematologic Malignancies
09/14/2019 ANCO's 3Q2019 Hematologic Malignancies Updates: Leukemias, Lymphomas, & Myeloma
09/06/2019 ASCO Quality Care Symposium
09/05/2019 ASCO Oncology Practice Conference
09/04/2019 5th World Congress on Controversies in Breast Cancer (CoBrCa): When is Less More?
08/17/2019 ANCO's ASCO Highlights 2019
07/25/2019 20th Annual International Lung Cancer Congress
07/19/2019 Best of ASCO
07/12/2019 ASCO Direct Highlights--An ACCC and HSCO Collaboration
06/21/2019 MASCC/ISOO Annual Meeting: Supportive Care in Cancer
06/13/2019 Value-Based Payment Program Performance Measures: What Physicians Need to Know About the Inventive Payments
06/08/2019 The 2019 Patient Conference on Prostate Cancer
05/22/2019 The Independent Dispute Resolution Process
05/18/2019 ANCO's Hematologic Malignancies Updates: Leukemias, Lymphomas, & Myeloma
05/16/2019 Frontline Advancements: Clinical Data Overview of Echelon-1 and Echelon-2
05/13/2019 HealthIT 2019 After Meaningful Use
05/04/2019 Inaugural American Initiative in Mast Cell Diseases (AIM)
05/01/2019 Frontline Advancements: Clinical Data Overview of Echelon-1 and Echelon-2
04/16/2019 New Directions in the Management of Recurrent Ovarian Cancer
03/15/2019 19th Multidisciplinary Management of Cancers: A Case-Based Approach

Apply to Become a Member


4225 Solano Ave, #764
Napa, CA 94558
Phone (415) 472-3960

Association of Northern California Oncologists © 2025 | Privacy Policy | Disclaimer

Powered by Wild Apricot Membership Software